Vnitr Lek 2006, 52(11):1021-1029

Late complications of chronic respiratory infections in patients with common variable immunodeficiency

O. Kopecký1,*, Š. Lukešová1, V. Koblížek3, V. Vroblová1, J. Novotný2
1 Ústav klinické imunologie a alergologie Lékařské fakulty UK a FN Hradec Králové, přednosta MUDr. Otakar Kopecký, CSc.
2 Radiologická klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Pavel Eliáš, CSc.
3 Plicní klinika Lékařské fakulty UK a FN Hradec Králové, přednosta doc. MUDr. František Salajka, CSc.

Common variable immunodeficiency (CVID) is the most frequent serious humoral deficiency manifested in adulthood in the form of acute and chronic respiratory infections which in most patients lead to respiratory failure. Retrospective analysis of 28 CVID patients was made. Mean age at time of diagnosis was 38.6 ± 18.6 years. The time which elapsed from the first symptoms to determining the diagnosis was three times as long as that indicated in other studies, i.e. 14.1 ± 10.2 years. Twenty-three patients (82.1 %) had respiratory complications. Chronic obstructive pulmonary diseases, n = 16 (57.1 %), and bronchiectasis, n = 10 (35.7 %), were the most frequent types of lung damage. In addition, two patients (7.1 %) displayed evidence of interstitial lung process. Morbidity associated with CVID can be reduced by early diagnosis and adequate dosage of immunoglobulins to minimise the occurrence and progression of lung damage.

Keywords: bronchiectasis; interstitial lung process; antibody deficiency; common variable immunodeficiency; lung damage

Received: November 28, 2005; Accepted: June 29, 2006; Published: November 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kopecký O, Lukešová Š, Koblížek V, Vroblová V, Novotný J. Late complications of chronic respiratory infections in patients with common variable immunodeficiency. Vnitr Lek. 2006;52(11):1021-1029.
Download citation

References

  1. Aukrust P, Lien E, Kristoffersen AK et al. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency - possible immunologic and clinical consequences. Blood 1996; 87: 674-681. Go to original source...
  2. Bjoraker JA, Ryu JH, Edwin MK et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157: 199-203. Go to original source... Go to PubMed...
  3. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109: 1001-1004. Go to original source... Go to PubMed...
  4. Cadranel J, Bouvry D, Wislez M. Respiratory manifestations of common variable immunodeficiency in adults. Rev Mal Respir 2003; 20: 126-133. Go to PubMed...
  5. Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immune deficiency. J Clin Immunol 1989; 9: 22-33. Go to original source... Go to PubMed...
  6. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immun 1999; 92: 34-48. Go to original source... Go to PubMed...
  7. de Gracia J, Vendrell M, Álvarez A. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. International Immunopharmacol 2004; 4: 745-753. Go to original source... Go to PubMed...
  8. Grimbacher B, Hutloff A, Schlesier M et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003; 4: 261-268 Go to original source... Go to PubMed...
  9. Hammarström L 2nd, Vorechovsky I, Webster D. Selective IgA deficiency (sIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000; 120: 225-231. Go to original source... Go to PubMed...
  10. Homolka J. Idiopathic pulmonary fibrosis: adverse prognosis in artificial respiration patients. Pneumologie 2002; 56: 161-162. Go to original source... Go to PubMed...
  11. Hutloff A, Bücher K, Reiter K et al. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3211-3220. Go to original source... Go to PubMed...
  12. Kainulainen L, Nikoskelainen J, Ruuskanen O. Diagnostic findings in 95 finnish patients with common variable immunodeficiency. J Clin Immunol 2001; 21: 145-149. Go to original source... Go to PubMed...
  13. Kainulainen L, Nikoskelainen J, Vuorinen T et al. Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respir Crit Care Med 1999; 159: 1199-1204. Go to original source... Go to PubMed...
  14. Kainulainen L, Varpula M, Liippo K et al. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 1999; 104: 1031-1036. Go to original source... Go to PubMed...
  15. Ko J, Radigan L, Cunningham-Rundles C. Switched memory B cells in common variable immunodeficiency. J Allergy Clin Immunol 2004; 113 (Suppl 1): S38. Go to original source...
  16. Kokron CM, Errante PR, Barros MT et al. Clinical and laboratory aspects of common variable immunodeficiency. An Acad Bras Cienc 2004; 76: 707-726. Go to original source... Go to PubMed...
  17. Lamari F, Karamanos NK, Papadopoulou-Alataki E et al. Monitoring of two intravenous immunoglobulin preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients. J Pharmaceut Biomed Analysis 2000; 22: 1029-1036. Go to original source... Go to PubMed...
  18. Litzman J, Burianova M, Thon V et al. Progression of selective IgA deficiency to common variable immunodeficiency in a 16 year old boy. Allergol Immunopathol (Madr) 1996; 24: 174-176. Go to PubMed...
  19. Losi CG, Silini A, Fiorini C et al. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. J Clin Immunol 2005; 25: 496-502. Go to original source... Go to PubMed...
  20. Popa V, Colby TV, Reich SB. Pulmonary interstitial disease in Ig deficiency. Chest 2002; 122: 1594-1603. Go to original source... Go to PubMed...
  21. Salzer U, Chapel HM, Webster ADB et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nature Gen 2005; 37: 820-828. Go to original source... Go to PubMed...
  22. Salzer U, Grimbacher B. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency. Curr Opin Allergy Clin Immunol 2005; 5: 496-503. Go to original source... Go to PubMed...
  23. Sewell WA, Buckland M, Jolles SR. Therapeutic strategies in common variable immunodeficiency. Drugs 2003; 63: 1359-1371. Go to original source... Go to PubMed...
  24. Thickett KM, Kumararatne DS, Banerjee AK et al. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM 2002; 95: 655-662. Go to original source... Go to PubMed...
  25. Thon V, Eggenbauer H, Wolf HM et al. Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired. Clin Exp Immunol 1997; 108: 1-8. Go to original source... Go to PubMed...
  26. Wang Y, Carter RH CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers. Immunity 2005; 22: 749-761. Go to original source... Go to PubMed...
  27. Warnatz K, Denz A, Dräger R et al. Severe deficiency of switched memory B cells (CD27+IgM-IgD-) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002; 99: 1544-1551. Go to original source... Go to PubMed...
  28. Webster AD Virus infections in primary immunodeficiency. J Clin Pathol 1994; 47: 965-967.
  29. Webster DB Common variable immunodeficiency. Immunol Allergy Clin North Am 2001; 21: 1-22. Go to original source...
  30. Weiler CR, Bankers-Fulbright JL Common variable immunodeficiency: test indications and interpretations. Mayo Clin Proc 2005; 80: 1187-1200. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.